Literature DB >> 11330342

Blocking effects of the antiarrhythmic drug propafenone on the HERG potassium channel.

J Mergenthaler1, W Haverkamp, A Hüttenhofer, B V Skryabin, U Musshoff, M Borggrefe, E J Speckmann, G Breithardt, M Madeja.   

Abstract

Propafenone has been shown to affect the delayed-rectifier potassium currents in cardiomyocytes of different animal models. In this study we investigated effects and mechanisms of action of propafenone on HERG potassium channels in oocytes of Xenopus laevis with the two-electrode voltage-clamp technique. Propafenone decreased the currents during voltage steps and the tail currents. The block was voltage-dependent and increased with positive going potentials (from 18% block of tail current amplitude at -40 mV to 69% at +40 mV with 100 micromol/l propafenone). The voltage dependence of block could be fitted with the sum of a monoexponential and a linear function. The fractional electrical distance was estimated to be delta=0.20. The block of current during the voltage step increased with time starting from a level of 83% of the control current. Propafenone accelerated the increase of current during the voltage step as well as the decay of tail currents (time constants of monoexponential fits decreased by 65% for the currents during the voltage step and by 37% for the tail currents with 100 micromol/l propafenone). The threshold concentration of propafenone effect was around 1 micromol/l and the concentration of half-maximal block (IC50) ranged between 13 micromol/l and 15 micromol/l for both current components. With high extracellular potassium concentrations, the IC50 value rose to 80 degrees mol/l. Acidification of the extracellular solution to pH 6.0 increased the IC50 value to 123 micromol/l, alkalization to pH 8.0 reduced it to 10 micromol/l and coexpression of the beta-subunit minK had no statistically significant effect on the concentration dependence. In conclusion, propafenone has been found to block HERG potassium channels. The data suggest that propafenone affects the channels in the open state and give some hints for an intracellular site of action.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11330342     DOI: 10.1007/s002100000392

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  8 in total

1.  Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action.

Authors:  Claudia Kiesecker; Edgar Zitron; Sonja Lück; Ramona Bloehs; Eberhard P Scholz; Sven Kathöfer; Dierk Thomas; Volker A W Kreye; Hugo A Katus; Wolfgang Schoels; Christoph A Karle; Johann Kiehn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-10-30       Impact factor: 3.000

2.  Inhibition of HERG K+ current and prolongation of the guinea-pig ventricular action potential by 4-aminopyridine.

Authors:  J M Ridley; J T Milnes; Y H Zhang; H J Witchel; J C Hancox
Journal:  J Physiol       Date:  2003-05-09       Impact factor: 5.182

3.  Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.

Authors:  Ashok A Paul; Harry J Witchel; Jules C Hancox
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

4.  Stereoselective Inhibition of the hERG1 Potassium Channel.

Authors:  Liliana Sintra Grilo; Pierre-Alain Carrupt; Hugues Abriel
Journal:  Front Pharmacol       Date:  2010-11-22       Impact factor: 5.810

5.  Mitragynine, an euphoric compound inhibits hERG1a/1b channel current and upregulates the complexation of hERG1a-Hsp90 in HEK293-hERG1a/1b cells.

Authors:  Yea Lu Tay; Azimah Amanah; Mohd Ilham Adenan; Habibah Abdul Wahab; Mei Lan Tan
Journal:  Sci Rep       Date:  2019-12-24       Impact factor: 4.379

6.  Regulation of antiarrhythmic drug propafenone effects on the c-type Kv1.4 potassium channel by PHo and K+.

Authors:  Zhiquan Wang; Shimin Wang; Jianjun Li; Xuejun Jiang; Neng Wang
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153

7.  How to solve the problems of docking into a symmetric binding site: the example of the HERG channel.

Authors:  Andrea Schiesaro; Lars Richter; Gerhard F Ecker
Journal:  Sci Pharm       Date:  2013-07-31

8.  Structural implications of hERG K+ channel block by a high-affinity minimally structured blocker.

Authors:  Matthew V Helliwell; Yihong Zhang; Aziza El Harchi; Chunyun Du; Jules C Hancox; Christopher E Dempsey
Journal:  J Biol Chem       Date:  2018-03-15       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.